Cesarean section scar hyperplasia usually presents as a localized elevated pink or purplish-red mass with a congested, hardened surface and edges that do not protrude into the normal skin, accompanied by itching and pain.
Proliferative scarring is usually seen after the healing of trauma, ulcers and local inflammatory lesions deep into the dermis. Clinical manifestations are localized elevated pink or purplish-red lumps, the surface is congested, the texture is hard, the edge does not protrude into the normal skin, accompanied by itching and pain symptoms.
Histologically, the edges of the mass are well defined, with a large amount of fibrous tissue proliferation, visible capillary dilatation, inflammatory cell infiltration and myofibroblasts. Scar proliferation usually lasts for 6 months to 2 years. Later, it will gradually become softer and flatter, and the itching and pain symptoms will gradually decrease and eventually disappear.
There are many treatment options for hyperplastic scarring, including surgical and non-surgical treatments, which should be applied in accordance with the doctor’s instructions. Non-surgical treatments include pressure reduction therapy, silicone patch or silicone gel topical application, medication (including oral medication, topical medication and intra-scar injection), laser therapy, plasma therapy, etc. However, there is no specific treatment, and at present, comprehensive treatment is the mainstay.